Financial Results, Patent Issues, Listing Transfers, Acquisitions, and Healthcare Conference Schedules - Research Report on Smith & Nephew, Align, Stereotaxis, Wright, and Volcano Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, August 30, 2013 NEW YORK, August 30, 2013 /PRNewswire/ -- Today, Investors' Reports announced new research reports highlighting Smith & Nephew plc (NYSE: SNN), Align Technology, Inc. (NASDAQ: ALGN), Stereotaxis, Inc. (NASDAQ: STXS), Wright Medical Group, Inc. (NASDAQ: WMGI), and Volcano Corporation (NASDAQ: VOLC). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Smith & Nephew plc Research Report On August 1, 2013, Smith & Nephew plc (Smith & Nephew) reported Q2 FY 2013 financial results (period ended June 29, 2013). In Q2 FY 2013, the Company achieved revenue of $1.1 billion, up 4.4% YoY. The Company also reported adjusted EPS of 18.0 cents, up 0.6% YoY, and basic EPS of 14.3 cents, down 55.9% YoY, during the quarter. "The on-going implementation of our Strategic Priorities underpinned our performance in the quarter. We generated stand-out contributions from our areas of focused investment in the Emerging and International Markets and Negative Pressure Wound Therapy. As expected Orthopaedic Reconstruction had a slow quarter and we anticipate a better second half," said Olivier Bohuon, CEO of Smith & Nephew. The Full Research Report on Smith & Nephew plc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-28/SNN] -- Align Technology, Inc. Research Report On August 26, 2013, Align Technology, Inc. (Align) announced the enforcement of permanent injunctions granted by a patent chamber of the District Court of Dusseldorf in the Federal Republic of Germany against Ortho Caps GmbH (Ortho Caps) and Rasteder KFO Spezial-Labor GmbH (Rasteder KFO). According to the Company, the District Court's decision comes in response to patent infringement lawsuits filed by Align against both Ortho Caps and Rasteder KFO in December 2011, asserting that both have infringed Align's patents by making, offering to sell, and selling their respective clear aligner therapy systems in Germany. Align further informed that the permanent injunctions were based on the Dusseldorf Court's finding that Ortho Caps and Rasteder KFO have separately infringed the German parts of European Patents EP 2 263 599, EP 2 263 598, EP 1 369 091 as well as EP 1 143 872. The Full Research Report on Align Technology, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-28/ALGN] -- Stereotaxis, Inc. Research Report On August 16, 2013, Stereotaxis, Inc. (Stereotaxis) announced that the NASDAQ Listing Qualifications Panel on August 15, 2013 has granted approval to the Company's request to transfer its listing to The NASDAQ Capital Market from The NASDAQ Global Market. The Company further reported that pursuant to the approval, Stereotaxis' securities will trade on the NASDAQ Capital Market with effect from August 19, 2013. The Full Research Report on Stereotaxis, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-28/STXS] -- Wright Medical Group, Inc. Research Report On August 21, 2013, Wright Medical Group, Inc. (Wright) announced that it will participate in the Baird 2013 Health Care Conference, to be held at the New York Palace Hotel in New York, on Wednesday, September 11, 2013. Wright's CFO Lance Berry will represent the Company at the conference at 11:25 a.m. ET. In other news dated August 20, 2013, the Company announced that it will participate in the Morgan Stanley Global Healthcare Conference to be held at the Grand Hyatt Hotel on September 10, 2013 in New York. Wright's President and CEO Robert Palmisano will present on behalf of the Company on the scheduled date at 8:35 a.m. ET. The Full Research Report on Wright Medical Group, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-28/WMGI] -- Volcano Corporation Research Report On August 26, 2013, Volcano Corporation (Volcano) announced that it has signed an agreement to acquire the Pioneer Plus diagnostic ultrasound transducer and percutaneous catheter from Medtronic, Inc. (Medtronic). According to the Company, the transaction is structured as an asset purchase and it expects the deal to close by the end of August 2013, subject to customary closing conditions. "With the completion of this transaction, the Pioneer Plus device will represent a further expansion of our peripheral therapeutics product line," said Scott Huennekens, President and CEO of Volcano. Huennekens continued, "At the end of 2012, we acquired the Crux Vena Cava Filter (VCF) System, a highly differentiated inferior vena cava (IVC) filter. We are readying a full market launch for the Crux device in the first half of 2014, while continuing our development program to combine our IVUS technology with the Crux VCF System." The Full Research Report on Volcano Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-28/VOLC] ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. InvestorsReports.com SOURCE Investors' Reports Contact: Kristi Saunders, +1-315-982-6420 (North America)
Financial Results, Patent Issues, Listing Transfers, Acquisitions, and Healthcare Conference Schedules - Research Report on
Press spacebar to pause and continue. Press esc to stop.